Effect of Zuogui Jiangtang Tongmai Prescription on Astrocyte Injury by AGEs Combined with Oxygen-glucose Deprivation Based on AMPK/mTOR/ULK1 Pathway Related to Autophagy
|更新时间:2022-07-14
|
Effect of Zuogui Jiangtang Tongmai Prescription on Astrocyte Injury by AGEs Combined with Oxygen-glucose Deprivation Based on AMPK/mTOR/ULK1 Pathway Related to Autophagy
Chinese Journal of Experimental Traditional Medical FormulaeVol. 28, Issue 16, Pages: 90-99(2022)
LI Yujia,LI Dingxiang,PENG Xun,et al.Effect of Zuogui Jiangtang Tongmai Prescription on Astrocyte Injury by AGEs Combined with Oxygen-glucose Deprivation Based on AMPK/mTOR/ULK1 Pathway Related to Autophagy[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(16):90-99.
LI Yujia,LI Dingxiang,PENG Xun,et al.Effect of Zuogui Jiangtang Tongmai Prescription on Astrocyte Injury by AGEs Combined with Oxygen-glucose Deprivation Based on AMPK/mTOR/ULK1 Pathway Related to Autophagy[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(16):90-99. DOI: 10.13422/j.cnki.syfjx.20221541.
Effect of Zuogui Jiangtang Tongmai Prescription on Astrocyte Injury by AGEs Combined with Oxygen-glucose Deprivation Based on AMPK/mTOR/ULK1 Pathway Related to Autophagy
To explore the effect and mechanism of Zuogui Jiangtang Tongmai prescription (ZGJTTMP) on astrocytes (ASs) injured by advanced glycation end products(AGEs) combined with oxygen-glucose deprivation (OGD).
Method
2
Cell counting kit-8 (CCK-8) was used to determine the optimal concentration of AGEs and the action time of OGD, and the optimal blood concentration of ZGJTTMP was selected for follow-up experiments. ASs were divided into normal group, model group (AGEs + OGD), ZGJTTMP group, an adenosine 5'-monophosphate-activated protein kinase (AMPK) inhibitor (Compound C) group, AMPK activator (AICAR) group, and combination group (ZGJTTMP + AICAR). The morphological changes in ASs in each group were observed under an inverted microscope. The cell survival rate in each group was detected by CCK-8. The content of interleukin-1
β
(IL-1
β
), interleukin-6(IL-6), and tumor necrosis factor-
α
(TNF-
α
) was detected by enzyme-linked immunosorbent assay (ELISA). The number of autophagosomes in each group was counted under an electron microscope. The expression of microtubule-associated protein light chain 3 (LC3) was observed by immunofluorescence. The protein expression of LC3, p62, p-AMPK, AMPK, p-mammalian target of rapamycin (mTOR), mTOR, p-UNC-51 like kinase 1 (ULK1), and ULK1 was detected by Western blot.
Result
2
According to the results of cell survival rate, 200 mg·L
-1
AGEs and OGD for 6 h were selected as the optimal modeling conditions for the model group, and 5% was selected as the optimal blood concentration of ZGJTTMP. Under the inverted microscope, the cells were severely damaged after modeling, but the cell injury in the ZGJTTMP group and the Compound C group was significantly improved. As revealed by ELISA results, the content of IL-1
β
, IL-6, and TNF-
α
in the model group increased (
P
<
0.01), and the content of inflammatory factors in the ZGJTTMP group and the Compound C group decreased (
P
<
0.01). Under the electron microscope, the number of autophagosomes in the model group increased significantly. The immunofluorescence results showed that the expression area of LC3 increased in the model group (
P
<
0.01), and the ZGJTTMP group and the Compound C group showed decreased number of autophagosomes and reduced expression area of LC3 (
P
<
0.01). As demonstrated by the results of Western blot, compared with the normal group, the model group showed increased expression of LC3Ⅱ/LC3Ⅰ and p-AMPK/AMPK (
P
<
0.01) and decreased p62, p-mTOR/mTOR, and p-ULK1/ULK1 (
P
<
0.01). Compared with the model group, the ZGJTTMP group and the Compound C group showed decreased expression of LC3Ⅱ/LC3Ⅰ and p-AMPK/AMPK (
P
<
0.01) and increased p62, p-mTOR/mTOR, and p-ULK1/ULK1 (
P
<
0.01).
Conclusion
2
ZGJTTMP possesses a protective effect on ASs with inflammatory injury by AGEs combined with OGD, which may be achieved by inhibiting the activation of the AMPK/mTOR/ULK1 pathway related to autophagy, thus inhibiting the overexpression of autophagy.
关键词
Keywords
references
CHIVESE T , HOEGFELDT C A A , WERFALLI M , et al . IDF Diabetes Atlas:The prevalence of pre-existing diabetes in pregnancy-A systematic review and Meta-analysis of studies published during 2010-2020 [J]. Diabetes Res Clin Pract , 2022 , 183 : 109049 .
LI Y Q , FU S , WANG L , et al . Autophagy and hypoxic ischemic brain injuries [J]. Acta Physiol Sinica , 2017 , 69 ( 3 ): 316 - 324 .
WEI N , YU S P , GU X H , et al . The involvement of autophagy pathway in exaggerated ischemic brain damage in diabetic mice [J]. CNS Neurosci Ther , 2013 , 19 ( 10 ): 753 - 763 .
OOSTERMAN J E , BELSHAM D D . Glucose alters per2 rhythmicity independent of AMPK,whereas AMPK inhibitor Compound C causes profound repression of clock genes and AgRP in mHypoE-37 hypothalamic neurons [J]. PLoS One , 2016 , 11 ( 1 ): e0146969 .
GUO X X , JIANG Q , ALESSANDRA T , et al . The AMPK-PGC-1 α signaling axis regulates the astrocyte glutathione system to protect against oxidative and metabolic injury [J]. Neurobiol Dis , 2018 , 113 : 59 - 69 .
SRUTHI C R , RAGHU K G . Advanced glycation end products and their adverse effects:The role of autophagy [J]. J Biochem Mol Toxicol , 2021 , 35 ( 4 ): 22710 .
SHELDON R , ELOY B , ALLEN T . Mechanistic targeting of advanced glycation end-products in age-related diseases [J]. Biochim Biophys Acta Mol Basis Dis , 2018 , 1864 ( 12 ): 3631 - 3643 .
JHANWAR-UNIYAL M , WAINWRIGHT J V , MOHAN A L , et al . Diverse signaling mechanisms of mTOR complexes:mTORC1 and mTORC2 in forming a formidable relationship [J]. Adv Biol Regul , 2019 , 72 : 51 - 62 .
WANG Y , XU W , YAN Z , et al . Metformin induces autophagy and G 0 /G 1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways [J]. J Exp Clin Cancer Res , 2018 , 37 ( 1 ): 63 .
WANG J F , MEI Z G , FU Y , et al . Puerarin protects rat brain against ischemia/reperfusion injury by suppressing autophagy via the AMPK-mTOR-ULK1 signaling pathway [J]. Neural Regen Res , 2018 , 13 ( 6 ): 989 - 998 .